Diabetic Nephropathy Amelioration by a Low-Dose Sitagliptin in an Animal Model of Type 2 Diabetes (Zucker Diabetic Fatty Rat)
Figure 4
Effects of chronic sitagliptin treatment on renal glomerular and tubulointerstitial lesions in obese diabetic ZDF rats, at the final time (26 weeks). Data is expressed as mean ± sem of 8 rats/group: * and ***. SITA, sitagliptin.